3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 DiabetesNutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitusRecruitingPhase 12026-05-06NCT07568678
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsLocally Advanced Unresectable or Metastatic Solid TumorsRecruitingPhase 12026-05-04NCT05458219
Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)eye disorder, myopia, refractive errorRecruitingNot applicable2019-12-05NCT04187599